Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
77.40
-0.19 (-0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Tech Stalls As Rising Bond Yields Spook Investors
January 02, 2024
It's been an inauspicious start to the 2024 trading year, with all three major indexes in the red midday.
Via
Talk Markets
Moderna Analyst Projects Transformation Into 'Five-Product Commercial Company' By 2026
January 02, 2024
Moderna Inc (NASDAQ: MRNA) is back in focus as it is making advancements in cancer treatment.
Via
Benzinga
Moderna Stock Is Moving Higher: What's Going On?
January 02, 2024
Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday following positive analyst coverage from Oppenheimer.
Via
Benzinga
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
December 29, 2023
During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc.
Via
Benzinga
Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
December 29, 2023
The pair's collaboration is making waves, and there's more to come.
Via
The Motley Fool
This Is What Whales Are Betting On Moderna
December 21, 2023
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
December 18, 2023
Via
Benzinga
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations.
Via
Benzinga
Thoughts For Thursday: With War Clouds As A Backdrop The Market Is Set To End The Year On A High
December 28, 2023
The market looks set to end 2023 on a high note, but 2024 is less certain, particularly because though, the US does not want further action in the Gulf, it seems, Iran via its proxies is gaming for...
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
Via
Benzinga
The Winners and Losers: 2023 Stock Market Performance Review
December 27, 2023
The 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't).
Via
InvestorPlace
Why Is RayzeBio (RYZB) Stock Up 100% Today?
December 26, 2023
RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio. Expect more such deals in 2024.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
Via
Benzinga
Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?
December 25, 2023
Some of this year's underperformers could have brighter futures.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
HBM Gets Health Boost From Drug Licensing Deals
December 22, 2023
Key Takeaways: Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05...
Via
Benzinga
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
December 22, 2023
The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n
Via
Benzinga
Exposures
COVID-19
Long-Term, Organic Revenue Growth Is A Key To Investment Success
December 20, 2023
Revenue growth is probably the easiest of the 4 check boxes to quantify. Anyone can pull up their broker's research pages, or Yahoo Finance, and look at the past 3 or 5 years of revenue.
Via
Talk Markets
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
December 20, 2023
One retail chain may have the clearest path to market-beating upside from here.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
QQQ And QQQM ETFs Top Gainers And Laggards Of 2023
December 20, 2023
This article will look at the top gainers and laggards of the two popular ETFs, which have over $17 billion and $223 billion assets, respectively. The two funds are similar, with the only difference...
Via
Talk Markets
Topics
ETFs
Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now
December 19, 2023
Avoid these f-rated stocks like the plague in order to help keep your portfolio squeaky clean in the new year.
Via
InvestorPlace
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
December 19, 2023
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...
Via
Benzinga
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
December 18, 2023
Analysts think these beaten-down stocks could rebound strongly in the new year.
Via
The Motley Fool
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
December 18, 2023
Moderna's personalized cancer vaccine candidate just delivered excellent clinical trial results.
Via
The Motley Fool
Moderna Entering Weekly Bluebox Support Area
December 17, 2023
Moderna, Inc. is an US American pharmaceutical and biotechnology company. Founded in 2010 and headquartered in Cambridge, Massachusetts, USA, it is a part of NASDAQ100 and S&P500 indices.
Via
Talk Markets
3 S&P 500 Stocks That Are About to Get Absolutely Crushed
December 16, 2023
Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
December 16, 2023
The U.S. Food and Drug Administration (FDA) identified several quality control issues at the primary manufacturing facility of Moderna Inc. (NASDAQ: MRNA)
Via
Benzinga
Exposures
Product Safety
Barron's Weekend Stock Picks: Nokia, Roku, Nvidia And Moderna's Latest Cancer Treatment Trial
December 16, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review
December 15, 2023
The Dow hit a record high while the S&P 500 and Nasdaq set 2023 bests.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 No-Brainer Healthcare Stocks to Buy Right Now
December 15, 2023
These players have what it takes to boost your portfolio over time.
Via
The Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.